These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 11718214

  • 21. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA, Anagnostopoulos A, Anderson K, Branagan AR, Coleman M, Frankel SR, Giralt S, Levine T, Munshi N, Pestronk A, Rajkumar V, Treon SP.
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [Abstract] [Full Text] [Related]

  • 22. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
    Niitsu N, Hayama M, Okamoto M, Khori M, Higashihara M, Tamaru J, Hirano M.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):4077-82. PubMed ID: 15217942
    [Abstract] [Full Text] [Related]

  • 23. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B, Santos ES.
    Expert Rev Anticancer Ther; 2007 Mar 15; 7(3):257-73. PubMed ID: 17338647
    [Abstract] [Full Text] [Related]

  • 24. Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
    Hess G, Flohr T, Huber C, Kolbe K, Derigs HG, Fischer T.
    Bone Marrow Transplant; 2003 May 15; 31(9):775-82. PubMed ID: 12732884
    [Abstract] [Full Text] [Related]

  • 25. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N, Ishibashi K, Uno H, Hino N.
    Gan To Kagaku Ryoho; 2002 Dec 15; 29(13):2569-72. PubMed ID: 12506485
    [Abstract] [Full Text] [Related]

  • 26. Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
    Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM.
    J Clin Oncol; 2005 Aug 01; 23(22):5044-51. PubMed ID: 15955901
    [Abstract] [Full Text] [Related]

  • 27. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Mandigers CM, Verdonck LF, Meijerink JP, Dekker AW, Schattenberg AV, Raemaekers JM.
    Bone Marrow Transplant; 2003 Dec 01; 32(12):1159-63. PubMed ID: 14647270
    [Abstract] [Full Text] [Related]

  • 28. Rituximab therapy for indolent non-Hodgkin's lymphoma.
    Hagenbeek A, Czuczman MS, Ghielmini M, Herold M, Kimby E, Solal-Céligny P, Unterhalt M.
    Anticancer Drugs; 2002 Nov 01; 13 Suppl 2():S11-7. PubMed ID: 12710586
    [Abstract] [Full Text] [Related]

  • 29. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
    Ratanatharathorn V, Pavletic S, Uberti JP.
    Cancer Treat Rev; 2009 Dec 01; 35(8):653-61. PubMed ID: 19682801
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Rituximab resistance in B-cell lymphoma and its elimination].
    Hatake K, Terui Y.
    Gan To Kagaku Ryoho; 2009 Apr 01; 36(4):548-51. PubMed ID: 19381025
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Rituximab].
    Okamoto R, Maeda Y, Sasaki T.
    Gan To Kagaku Ryoho; 2003 Aug 01; 30(8):1085-93. PubMed ID: 12938262
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
    Eisenbeis CF, Grainger A, Fischer B, Baiocchi RA, Carrodeguas L, Roychowdhury S, Chen L, Banks AL, Davis T, Young D, Kelbick N, Stephens J, Byrd JC, Grever MR, Caligiuri MA, Porcu P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6101-10. PubMed ID: 15447996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.